📰 Boxed Warning News
Page 52 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
February 28, 2022
/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and full year 2021 financial results and host a...
February 28, 2022
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...
February 25, 2022
Elyxyb (celecoxib oral solution) is now available for the acute treatment of migraine with or without aura in adults.
February 24, 2022
Data from the innovaTV 207 global phase 2 trial to be presented at the American Society for Radiation Oncology (ASTRO) 2022 Multidisciplinary Head and Neck Cancers Symposium Genmab A/S (Nasdaq:
February 24, 2022
Data from the innovaTV 207 global phase 2 trial to be presented at the American Society for Radiation Oncology (ASTRO) 2022 Multidisciplinary Head and Neck Cancers Symposium Seagen Inc. (Nasdaq:
February 23, 2022
Health care professionals should be advised of the potential risks of using compounded ketamine nasal spray to treat psychiatric disorders.
February 17, 2022
Health care professionals should be advised of the potential risks of using compounded ketamine nasal spray to treat psychiatric disorders.
February 9, 2022
- LYBALVI Demonstrated Less Weight Gain Compared to Olanzapine in Patients With Schizophrenia, Schizophreniform Disorder or Bipolar I Disorder - DUBLIN, Feb. 8, 2022 /PRNewswire/ -- Alkermes
February 9, 2022
JAK inhibitors discontinuation and retention rates were similar to those for biologic disease-modifying antirheumatic drugs in large Canadian RA data sets.
February 8, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of...